Ms Jo Close, Chair

BBiotech (Hons) GAICD GLF10

Jo Close is Business Development Director with Aucentra Therapeutics, an Australian biotech company working in collaboration with the University of South Australia to develop advanced, breakthrough anti-cancer drugs. Jo leads the strategic development of Aucentra towards planned expansion of clinical activities, transitioning discoveries into clinical trials.

Jo is a scientist with an accomplished career in research strategy and management. She has managed major Centres, Institutes and programs within all three leading South Australian universities and undertaken formative roles within the local bioscience industry and investment sector. For five years, Jo ran a successful consulting business, primarily facilitating local research organisations to develop strategy and plan major, collaborative research projects.

Jo has also established and led a range of industry development programs for local and international markets. Her contributions expand to the fundraising and community development areas, where Jo has driven a range of high-impact initiatives. Jo has completed the Company Director’s Course and is a fellow of the Governor’s Leadership Foundation.

Mr Lachlan Monfries, Deputy Chairman


Lachlan joined the Cure4CF board in 2015. He knows first-hand the effects of cystic fibrosis and wanted to join the fight and support the Foundation’s efforts to find a cure.  At the 2018 Cure4CF Annual General Meeting, Lachlan was unanimously voted in as Deputy Chairman, a role which he describes as an honour and privilege. Lachlan is currently Centre Manager at Westfield Marion. He has worked for Westfield for the past 12 years and has experience in a number of marketing and management roles across Victoria and South Australia.


Stephanie Morris

GAICD, MBA, BBus, DipBioMedSci

Director of Industry Partnerships and Commercialisation, Medicine Imperial College London.

Stephanie is a life-sciences professional with enthusiasm for invention, technology transfer and commercialisation. She currently heads the translational activities for academic discovery and innovation for the Faculty of Medicine at Imperial College London. She has depth of expertise having worked within start-up companies, SMEs and large multinational pharmaceutical organisations at operational and governance levels. She has a unique breadth of experience across the full care continuum, including academia, R&D, clinical development, commercialisation, as well as working with patients in both acute and chronic settings in the community.

Stephanie brings a dynamic and global perspective to research commercialisation. She holds tertiary qualifications in both biomedical science and in business, has a Master’s in Business Administration (MBA) and is a graduate of the Australian Institute of Company Directors (AICD).

Mr Clinton Jury, Director


Clinton joined the Board in August 2018 and we welcomed his extensive not-for-profit and fundraising experience.  Clinton is currently the State Manager SA/NT for the Australian Institute of Company Directors (AICD) and has extensive experience in leading organisations across adult education, strategic project management, marketing and commercial operations as well as major fundraising programs and member and volunteer management.  Holding senior Director and Management roles in the NFP sector for more than 25 years Clinton has worked across many organisations including the Women’s and Children’s Hospital Foundation, Australian Red Cross, Royal Flying Doctor Service & CanTeen. Clinton is passionate about the creation of vibrant communities which bring people together and is excited to work alongside the CF community in search of a cure.

kay-li-cure4cfKayi Li


Financial Controller and Investor Relations Manager Codan Limited.

Kayi is currently the Financial Controller and Investor Relations manager with Codan Limited. Working for a diverse multinational company has allowed Kayi to accumulate a wealth of accounting and management experience across different industries both domestically and internationally. She holds tertiary qualifications in Commerce from the University of South Australia, a member of Chartered Accountants of Australia and New Zealand, has a Master’s in Business Administration and is a graduate of the Australian Institute of Company Directors.

Ms Megan Webster Bradman

BA, LLB(Hons), MPA

Megan is currently an Executive Director with the Department of the Premier and Cabinet, and has extensive experience interacting with all three tiers of government. Passionate about supporting the local community, Megan has held a variety of board roles and in 2009 was nominated to the Roll of Inspiring Women in South Ausralia.

Megan is also a qualified solicitor and barrister admitted to practise in the Supreme Court of South Australia, and is a member of the Law Society of South Australia.

Mr Greg Savage

BCom, GradDipBusAdm

Greg is an experienced manufacturing executive with expertise in engineering and continuous process operations. He is currently General Manager, Glass for Orora Limited.

Greg has been a manufacturing plant manager in Melbourne, Sydney and Brisbane over a 15 year period. The Sydney plant is one of the largest glass plants in the world with four furnaces, ten machine lines and 460 employees.

Managing more than 450 employees across two sites at the Spotswood Glass Plant and Box Hill Engineering facility, Greg led a major restructuring and business turn around in safety, quality, production efficiency and industrial relations relationships.

Mr Greg Oke

BAppSc (Met), MBA, MCIPS

Greg has considerable experience in the promotion of cystic fibrois and raising funds to support research into a cure. Greg was also on the board of The Cystic Fibrosis Association of South Australia Inc.

Greg is currently managing his own business and has significant senior management experience in the mining, automotive and manufacturing industries.